483 Evonik Rexim (Nanning) Pharmaceutical Sep 2018

483 Evonik Rexim (Nanning) Pharmaceutical Sep 2018

Steven Donald FDA$119.00 - Available Now

FDA investigators audited the Evonik Rexim (Nanning) Pharmaceutical - Nanning, China facility and issued inspectional observations (via FDA 483) on 28 Sep 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 28 Sep 2018
  • Location: Nanning, China
  • FEI: 3004268442
Add To Cart